Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: quidditch who wrote (3030)	5/26/1999 11:20:00 AM
From: j_fir2	Respond to of 10280

Newbies: Please note that SI has a search function at the bottom of the screen for content on this thread as well as elsewhere. Please use it. I think I can speak for this thread when I say that we expect you to have done your due diligence on this stock if you are here.

To: quidditch who wrote (3030)	5/26/1999 1:09:00 PM
From: LLCF	Respond to of 10280

< The market seems to be discounting the predominant part of allergy-product revenues right now.> Although I agree this could be true, I will save several people on the thread the trouble and tell you I got severely abused by suggesting this. DAK

To: quidditch who wrote (3030)	5/26/1999 2:18:00 PM
From: Don Miller	Respond to of 10280

IgE Blocker, Comment correction According to our MD's here and on YC IgE Blockers are NOT REPEAT NOT a serious threat possibly ever, but no sooner than many years away. Sorry I was typing too fast (10-10 wpm), them proof reading at 2000 wpm. Please search on authors asthmadoc99, pittsbull and IMARANGERBOY on SI, Yahoo club and Yahoo to get their comments on IgE Blocker potential from them directly. I was initially encouraged by the thought that a once a month shots would not be that much trouble for me personally, especially if it worked. I am an allergy sufferer and I have given myself shoots in times past. One of the above MDs' said it probably would not help asthma sufferers that exhibit no allergy symptoms. What I are also know is the above three responders are at the firing line every day, they better than anybody knew what the consumer and the HMO's will buy. Granted they do own stock, and not any one of the three is selling as of their last response, after the latest IgE Blocker compound discussion, today's stock price could be an another issue altogether. One of the three just heard about at a seminar in February, and essentially blew it off. He reported that not one MD raised a question after the presention. For me personally I use a drug called Flonase, which is the best thing I have ever used, and therefore see it to be the most significant threat to SEPR. It takes two weeks to get the onset in place and lasts more than 24 hours should I forget to inhale one morning. I still have to take my antihistamine once in a while when my allergens are particularly high. Neither drug can treat me for mite dust, which is my very worst allergen. I might add most of we posters and stock owners are "sensitized" in some way to the alleviation of allergy or asthma symptoms. We know the pleasure of symptom relief, so may be we value it more than others, and may be even over value it. If "we" as a group have a blind side for this stock, I would suggest we watch that soft point very carefully.